Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

CRL holding history

Charles River Laboratories International, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRL overviewAll 13F holders of CRLFull Q2 2026 holdings

Shares (Q2 2026)
2,168
Value
$491.7K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of CRL by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,168$491.7K<0.1%−199,455−98.9%ReducedHolders
Q1 2026201,623$34.8M0.2%−518−0.3%ReducedHolders
Q4 2025202,141$40.3M0.2%−27,950−12.1%ReducedHolders
Q3 2025230,091$36.0M<0.1%+227,433+8,556.5%AddedHolders
Q2 20252,658$403.3K<0.1%−48,926−94.8%ReducedHolders
Q1 202551,584$7.76M<0.1%+9,923+23.8%AddedHolders
Q4 202441,661$7.33M<0.1%+38,250+1,121.4%AddedHolders
Q3 20243,411$671.9K<0.1%+1,100+47.6%AddedHolders
Q2 20242,311$477.4K<0.1%−32,324−93.3%ReducedHolders
Q1 202434,635$9.38M<0.1%+6,135+21.5%AddedHolders
Q4 202328,500$6.74M<0.1%+13,214+86.4%AddedHolders
Q3 202315,286$3.00M<0.1%−595−3.7%ReducedHolders
Q2 202315,881$3.34M<0.1%−5,555−25.9%ReducedHolders
Q1 202321,436$4.33M<0.1%+14,508+209.4%AddedHolders
Q4 20226,928$1.51M<0.1%−3,652−34.5%ReducedHolders
Q3 202210,580$2.08M<0.1%+4,853+84.7%AddedHolders
Q2 20225,727$1.23M<0.1%+4,513+371.7%AddedHolders
Q1 20221,214$345.0K<0.1%−96−7.3%ReducedHolders
Q4 20211,310$493.0K<0.1%−748−36.3%ReducedHolders
Q3 20212,058$849.0K<0.1%−339−14.1%ReducedHolders
Q2 20212,397$887.0K<0.1%+617+34.7%AddedHolders
Q1 20211,780$515.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.